Global Access to Cell Therapy Requires Regulatory Adaptation and Flexibility

Published on ISCT Telegraft Blog by Francheska Juliano

At the ISCT 2024 Annual Meeting in Vancouver, global experts discussed how access to cell and gene therapies hinges on harmonized yet flexible regulatory approaches. Discussions emphasized early engagement with regulators, leveraging real-world evidence, and enabling local manufacturing to address access gaps. Case studies from India, Canada, and Singapore highlighted tailored frameworks that promote innovation while maintaining safety. A key message: regulation must evolve in step with technology to ensure timely and equitable patient access to advanced therapies.

Read the full article on ISCT:

👉 Perspective on Regulation and Access: Insights from the ISCT 2024 Annual Meeting

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link.